This list is an analysis based on recent market events. It's not an investment recommendation.
About
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
The current price of RVLP is $0.03 USD — it has decreased by -32.05% in the past 24 hours. Watch RVL Pharmaceuticals stock price performance more closely on the chart.
What is RVL Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange RVL Pharmaceuticals stocks are traded under the ticker RVLP.
What is RVL Pharmaceuticals market cap?▼
Today RVL Pharmaceuticals has the market capitalization of 2.8M
What is RVL Pharmaceuticals revenue for the last year?▼
RVL Pharmaceuticals revenue for the last year amounts to 49.72M USD.
What is RVL Pharmaceuticals net income for the last year?▼
RVLP net income for the last year is -51.69M USD.
How many employees does RVL Pharmaceuticals have?▼
As of April 01, 2026, the company has 156 employees.
In which sector is RVL Pharmaceuticals located?▼
RVL Pharmaceuticals operates in the Manufacturing sector.
When did RVL Pharmaceuticals complete a stock split?▼
RVL Pharmaceuticals has not had any recent stock splits.
Where is RVL Pharmaceuticals headquartered?▼
RVL Pharmaceuticals is headquartered in Bridgewater, IE.